Teleflex Stock - Analyst views and background on the medical device maker

Edited by ad hoc news Background & Management Desk. Verified prior to publication on 06/21/2026, 06:00 UTC. Details in the imprint.

Teleflex Inc. (US8793691069) remains a steady name in US medical technology, with its shares trading on the New York Stock Exchange under the ticker TFX according to exchange data. This Sunday background piece looks at how analysts currently view the company and what drives its business.

How analysts currently rate Teleflex

There has been no major new analyst note or rating change on Teleflex reported by top-tier outlets in the past day, but consensus data help frame sentiment. According to aggregated estimates, analysts generally maintain a mixed but cautious positive stance on the stock.

Market data platforms show that a majority of covering brokers rate Teleflex at or around a Buy-equivalent, while a smaller group sits at Hold. Target prices cluster above recent trading levels, implying moderate upside potential based on current models.

Background on earnings and growth drivers

In its recent quarterly reporting, Teleflex highlighted growth in interventional urology and vascular access, partly offset by pricing pressures in some legacy product categories according to company disclosures. Management has emphasized portfolio simplification and cost discipline to support margins.

Hospital procedure volumes and capital spending trends remain key external drivers for Teleflex, as many of its products are used in operating rooms and critical care. The company also points to opportunities from demographic aging and increased chronic disease prevalence in developed markets.

The product behind the stock

Teleflex generates most of its revenue from single-use medical devices such as Arrow-branded vascular access catheters and pressure monitoring kits, which are used in intensive care and surgical settings. Additional lines include urology, anesthesia and respiratory products sold to hospitals worldwide.

Where the stock trades today

Teleflex shares trade on the NYSE at around the mid-$120s range in recent sessions, with the stock priced at approximately $126.90 on low recent volatility according to market data.

This article was AI-assisted and editorially reviewed. Price and company data without warranty; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Trading securities involves risk up to total loss of capital.